Colesterolo-LDL e oltre: quali target e con quali terapie

Atherosclerotic cardiovascular disease is the leading cause of mortality, morbidity, and disability, and the presence of diabetes mellitus increases its progression and severity. SCORE2 charts are used for risk stratification in Europe. Circulating LDL cholesterol levels remain the primary reference biomarker and should be maintained within specific targets based on the severity of the risk. Current pharmacological therapy today offers a wide range of drugs that can be combined individually for optimal efficacy and safety.